Catherine M. Szyman Edwards Lifesciences Corp (EW) insider trading activity

Catherine M. Szyman is CVP, Critical Care of Edwards Lifesciences Corp. Currently has a direct ownership of 76,165 shares of EW, which is worth approximately $7.04 Million. The most recent transaction as insider was on May 08, 2023, when has been sold 1,376 shares (Common Stock) at a price of $88.74 per share, resulting in proceeds of $122,106. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.2K

75.6% 3M change

117.27% 12M change

Total Value Held $7.04 Million

Catherine M. Szyman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 08 2023	SELL Payment of exercise price or tax liability	$122,106 $88.74 p/Share	1,376 Reduced 4.6%	28,530 Common Stock
May 07 2023	SELL Payment of exercise price or tax liability	$191,145 $88.74 p/Share	2,154 Reduced 6.72%	29,906 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	4,708 Added 12.8%	32,060 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$30,306 $88.1 p/Share	344 Reduced 1.24%	27,352 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$28,713 $87.81 p/Share	327 Reduced 1.17%	27,696 Common Stock
Jul 07 2022	BUY Grant, award, or other acquisition	-	2,032 Added 5.43%	35,374 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$165,959 $95.93 p/Share	1,730 Reduced 4.94%	33,303 Common Stock

May 08 2022	SELL Payment of exercise price or tax liability	$746,663 $100.52 p/Share	7,428 Reduced 17.49%	35,033 Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	12,206 Added 22.33%	42,461 Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$59,809 $100.52 p/Share	595 Reduced 1.93%	30,255 Common Stock
May 04 2022	SELL Open market or private sale	$2,458,170 $105.05 p/Share	23,400 Reduced 43.13%	30,850 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$52,223 $105.93 p/Share	493 Reduced 0.9%	54,250 Common Stock
May 04 2022	BUY Exercise of conversion of derivative security	$509,184 $21.76 p/Share	23,400 Added 29.95%	54,743 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	3,775 Added 10.75%	31,343 Common Stock
Apr 11 2022	SELL Open market or private sale	$2,443,200 $122.16 p/Share	20,000 Reduced 42.05%	27,568 Common Stock
Apr 11 2022	BUY Exercise of conversion of derivative security	$435,200 $21.76 p/Share	20,000 Added 29.6%	47,568 Common Stock
Mar 14 2022	SELL Open market or private sale	$2,091,800 $104.59 p/Share	20,000 Reduced 42.18%	27,414 Common Stock
Mar 14 2022	BUY Exercise of conversion of derivative security	$435,200 $21.76 p/Share	20,000 Added 29.67%	47,414 Common Stock
Feb 18 2022	SELL Open market or private sale	$2,123,600 $106.18 p/Share	20,000 Reduced 42.18%	27,414 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	$435,200 $21.76 p/Share	20,000 Added 29.67%	47,414 Common Stock
Jan 14 2022	SELL Open market or private sale	$1,197,400 $119.74 p/Share	10,000 Reduced 26.73%	27,414 Common Stock
Jan 14 2022	BUY Exercise of conversion of derivative security	$217,600 $21.76 p/Share	10,000 Added 21.09%	37,414 Common Stock
Dec 17 2021	SELL Open market or private sale	$1,212,400 $121.24 p/Share	10,000 Reduced 26.73%	27,414 Common Stock
Dec 17 2021	BUY Exercise of conversion of derivative security	$217,600 $21.76 p/Share	10,000 Added 21.09%	37,414 Common Stock
Nov 18 2021	SELL Open market or private sale	$1,179,100 $117.91 p/Share	10,000 Reduced 26.73%	27,414 Common Stock

Also insider at

Outset Medical, Inc. Healthcare

Director

NARI

Inari Medical, Inc. Healthcare

Director

CMS